API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210073
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210002
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210213
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210160
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210172
https://www.pharmacompass.com/pdf/news/kazano-alogliptin-benzoate-metformin-hcltakeda-v-indoco-remedies-1517210432.pdf
http://www.pharmatimes.com/news/fda_rejects_cv_outcomes_claim_for_merck_diabetes_drugs_1191111
http://www.fiercepharma.com/pharma/takeda-s-nesina-heart-safe-for-acs-patients-new-analysis-says
http://www.fiercepharma.com/pharma/merck-s-dpp-4-newcomer-marizev-trails-januvia-safety-report
http://www.fiercepharma.com/story/fda-warning-jjs-invokana-adds-more-complexities-diabetes-drug-battles/2015-09-11?utm_medium=rss&utm_source=rss&utm_campaign=rss
http://www.fiercepharma.com/story/no-signal-heart-failure-risk-mercks-januvia-analysis-confirms/2015-08-31
http://in.reuters.com/article/2015/08/28/us-diabetes-drugs-warning-idINKCN0QX25E20150828
http://www.fiercepharma.com/story/record-new-drug-sales-give-mega-boost-us-drug-spending/2015-04-14
http://www.fiercepharma.com/story/astrazenecas-onglyza-mortality-risks-noted-fda-reviewers/2015-04-10
http://www.fiercepharma.com/story/azs-onglyza-has-most-lose-fda-safety-confab-analysts-say/2015-04-09